International Stem Cell Corporation (ISCO) Reports Positive Top-Line Preliminary Results from Parkinson’s Disease Clinical Trial
Tweet Send to a Friend
International Stem Cell Corporation (ISCO) announced today positive 12-month results of the first cohort and six-month interim results of the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
